Risk Analysis and Toxicology
In recent years, the concept of risk assessment has been used increasingly by toxicologists and health professionals. However, the definitions of terms concerned with such risk assessment are a source of confusion, are not widely accepted, and so hamper the understanding of the subject, presumably because it is still a recent and multidisciplinary field [ 1 ] .
Hazard is the ability to cause an adverse effect. As far as chemical substances are concerned, hazard includes flammability, explosivity, radioactivity, causticity and toxicity. Risk and hazard are definitely not synonyms. Risk is the probability that some harmful event will occur. Uncertainty is therefore a major component of risk. Risk assessment is the process which describes and quantifies the risk associated with exposure to a hazardous (toxic) substance. It is based on toxicological data obtained in animals, and possibly in humans, the evidence of a doseresponse relationship, and finally on data regarding the actual or estimated human exposure [2] . The words risk characterisation, evaluation or estimation are often used synonymously. They represent the process which attempts to produce an estimate of the likelihood of observing the toxic effect in the population under study. Finally, risk analysis is a global process which includes hazard identification, risk assessment, risk characterization and the perception of risk. Risk analysis, particularly as far as toxic substances are concerned, covers five aspects at least. The first aspect is hazard identification. Animal and, to a lesser extent, in vitro toxicity studies, are conducted to establish whether a given substance can cause toxic effects in humans. It should be emphasised that hazard identification is genuinely a qualitative process and the quality of the information provided depends on the choice of appropriate control groups, the use of sufficient numbers of animals, the selection of rigorous experimental protocols, the severity of the effects described and the relevance to man of the toxic mechanism involved. The result is a scientific judgement that the substance can cause toxic effects in humans at some exposure levels [3] . The second component of risk analysis is the origin or source of risk. This will include, for a substance, all relevant information on the composition of formulations containing it on the market (hence the need, seldom met, for a detailed description of all components and their respective concentration in the formulation), the name of all commercial products which include the substance, and the amount manufactured or distributed in a given period of time. The origin of risk should be kept under close scrutiny, for example, all relevant data about possible changes in use must be kept, such as, the amount manufactured, and changes in the recommended or actual modes of use.
Measurements of a substance in the air, water, food chain, or in biological fluids (blood or urine) are useful for quantifying the origin of risk. They are also useful for checking the effectiveness of preventive measures intended to decrease or control the risk. However, their usefulness is limited by several factors: the information obtained is always retrospective, the relevance of selected endpoints is often uncertain; and the cost of field studies is usually very high. Data are sometimes collected in very particular circumstances (e.g. real or simulated chemical catastrophes), but the relevance of the information gained in such extreme conditions is dubious.
Human exposure is the third component of risk analysis. Information should be obtained, where possible, on the duration, magnitude, and route(s) of exposure, and on the number and characteristics (e.g. gender, age, occupa-tional illness) of exposed individuals. When a therapeutic drug is given, a direct estimate of exposure is possible. Where occupational exposure is concerned, any estimate of exposure is less good. For environmental pollutants, mixtures of chemical substances, or ingredients included in formulations of household products, no good estimate of exposure is possible. The use of mathematical models is therefore required to estimate the level of exposure, even though no models, whatever their complexity, will ever totally compensate for the lack of objective data.
The fourth component of risk analysis is the nature and severity of expected health consequences. This can be determined from the incidence of a particular adverse event, e.g. death, in the population under study. Disease registries which record, for example, cancer or sentinel events, are extremely useful in this respect. Hazard identification is critical, but as extrapolation from animals to humans is always uncertain, the use of safety or uncertainty factors is widespread [4] . For risk analysis human data should ideally be available, particularly epidemiological data. Unfortunately, such data are few for methodological (complexity of events, confounding factors), ethical (expected toxicity for man) and/or financial (duration of studies, size of samples) reasons.
The characterisation or estimation of risk is the fifth and last component to be considered in risk analysis. Actually, it is seldom possible to measure a toxic risk very accurately as relevant data are often lacking. The estimation of risk is therefore usually grossly subjective. Comparative estimates are sometimes used, based on relative risks calculated from a theoretical scale, but such estimates are useless when it comes to deciding whether the risk is acceptable. A major component of risk is uncertainty [5] , which is typically dealt with by the use of safety or uncertainty factors. These are used to take account of such things as: errors in the measurement of effects, the retrospective nature of studies, the difficulties of data interpretation, the empirical nature of some observations, and the use of experimental or mathematical models. While all these factors are applied to allow for uncertainty, in reality interindividual variability in sensitivity to toxic effects is often the major factor. Every risk analysis is aimed at calculating whether the risk is acceptable, and if not, whether measures can be taken to reduce or control the risk [6] . Acceptability depends on the perception of risk which is markedly different in the general population or among experts, whether it is based on scientific, political, psychological, or cultural considerations [7] . The results of risk analysis must be logical, that is to say in general agreement with the current understanding of the problem; extensive to avoid oversimplification or confounding factors, and sensible to exclude excessive uncertainty. Risk is more likely to be unacceptable or unaccepted: if it is linked to a potential chemical catastrophe, however unlikely; or involves something unfamiliar, when children or future generations are involved; when it is a cause for anxiety; when it is linked to activities seen as having little value, and finally when the risk is irreversible or generated by man. The perception of risk is therefore always uncertain, influenced by more or less justified optimism or pessimism.
The analysis of risk in toxicology is far more than the mere assessment of risk based on toxicity data obtained in animal testing. It should be conducted rigorously and include the five components briefly described above. With a rigorous analysis of risk, it will be possible to conduct a sensible and reasonable management, based on measures aimed at its reduction or control. But importantly, even though the analysis of risk will be ultimately useful for judging whether the various factors and preventive measures had a positive influence, it has nothing to do with decision making or risk management, which should not be in the hands of toxicologists, but in those of politicians.
